Product Images Levetiracetam ER

This appears to be a graph representing the percentage of patients at different levels of response to a treatment for a condition. The treatment is not specified, but three different groups are shown: a group of six patients referred to as "Plaoeho," a group of seven patients treated with immediate-release levetiracetam at a dose of 1,000 mg/day, and a group of 101 patients treated with immediate-release levetiracetam at a dose of 3,000 mg/day. The graph shows that response rates varied between the groups, with the largest percentage of patients in the highest response category (39.6%) in the group treated with the highest dose of levetiracetam.*

This is a chart comparing the percentage of patients who received a placebo versus those who received immediate-release levetiracetam 3,000 mg/day. The chart shows that 14.4% of patients who received a placebo had positive effects, while 39.4% of patients who received levetiracetam had positive effects.*

This is a graph showing the percentage of patients with placebo (N=97) and immediate-release levetiracetam (N=101) with the corresponding percentage of patients on the Y-axis from 0-45%. The graph has two bars showing the results for each medication. However, there is no information on what these medications are for or what the percentages represent, so no further information can be determined.*

This is a medication information for Levetiracetam 500mg, which is administered for epilepsy treatment. It contains 30 oval-shaped tablets in a box. The tablets are debossed with "SG" on one side and "189" on the other side. The medication guide is packaged along with it. The manufacturer of these tablets is ScieGen Pharmaceuticals and it is marketed by Proficient Rx LP. The GTIN of the drug is 00371205728304, and the lot number specified is 00000. It is required to store this medication at a temperature between 20°-25°C (68°-77°F).*